G2S2 Capital Inc. ("G2S2") announces that its wholly owned subsidiary has disposed of common shares ("Shares") of Knight Therapeutics Inc. ("Knight") and no longer holds over 10% of Knight's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback